Home › Products › Oncology › Obrenza 150mg Tablet
Obrenza 150mg Tablet
Salt Composition: OLAPARIB
- Manufacturer: SUN PHARMACEUTICAL INDUSTRIES LTD
- Pack Size: 60 TABLET(s) IN A BOTTLE
- Dosage Form: TABLET
- Strength: 150MG
- Prescription Required
- Storage: Store Obrenza 100mg Tablet Tablet in the original package at room temperature (20°C to 25°C). Keep it out of reach from children.
₹19125.00₹23906.25
Inclusive of all taxes
Product Introduction
Obrenza 150mg Tablet is an anticancer medicine belonging to the PARP (poly [adenosine diphosphate-ribose] polymerase) inhibitor class. It contains the active ingredient Olaparib and is used in the treatment of pancreatic and prostate cancer. This medicine may be used alone or along with other cancer treatments.
Do not take Obrenza 150mg Tablet if you are allergic to Olaparib or any of its ingredients. Contact your doctor immediately if you experience symptoms such as breathlessness, chest pain, fast heartbeat, fever, cough, or wheezing. Regular blood tests are required before and during treatment, as this medicine may reduce red blood cells, white blood cells, and platelet counts.
Inform your doctor before starting treatment if you have any lung, liver, heart, or kidney problems. This medicine is not recommended during pregnancy as it may harm the unborn baby and increase the risk of miscarriage. Women who can become pregnant should take a pregnancy test before treatment and use effective contraception during therapy and for at least six months after completing treatment.
Breastfeeding is not recommended during treatment because it is unknown whether Olaparib passes into breast milk. Men should avoid donating sperm during treatment and for at least three months after finishing therapy. Inform your doctor about all medicines, supplements, and vitamins you are taking before starting Obrenza 150mg Tablet.
Uses
The uses of Obrenza 150mg Tablets include: Treatment of Prostate cancer Treatment of metastatic pancreatic cancer
How it works
Obrenza 100mg Tablet works by inhibiting the enzyme poly (ADP-ribose) polymerase (PARP), which plays a role in repairing damaged DNA in cells. By inhibiting PARP, Obrenza 100mg Tablet prevents cancer cells from repairing their DNA, leading to cell death. This targeted approach is especially effective in cancers with defective DNA repair mechanisms.
How to Use
The medicine will be prescribed to you by a healthcare professional in a hospital setting. Obrenza 100mg Tablet is available as a tablet to be taken with or without food, as directed by your healthcare provider. The dose will be decided by your healthcare professional based on your conditions. Avoid crushing, opening, or dissolving the tablet and swallow it whole with a glass of water. Take the Obrenza 100mg Tablet tablet at the same time every day.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Common side effects of Obrenza 150mg tablets are: Shortness of breath Nausea Vomiting Fatigue Dyspepsia Loss of appetite Dizziness Diarrhoea Headache Serious side effects of Obrenza 150mg Tablets are: Neutropenia Acute myeloid leukemia Leukopenia Thrombocytopenia Lung problems
Expert Tips
Obrenza 100mg Tablet can lower blood cell counts, thus it's best to get blood tests done at regular intervals. When undergoing this therapy, stay out of direct sunlight and wear sunscreen with an SPF of at least 50 before going outside. Obrenza 100mg Tablet should not be stopped without first talking to your doctor. When using this medication, stay away from grapefruit juice as it may raise your blood levels of the drug. It is recommended to inform your doctor about other anticancer drugs you have been taking. It's critical to maintain a sufficient fluid intake because dehydration can exacerbate symptoms such as diarrhea and other gastrointestinal disorders. Even if you feel better or see a change in your symptoms, you should still talk to your doctor before stopping Obrenza 100mg Tablet. Remember to attend all scheduled appointments and follow-up visits with your healthcare provider to ensure your treatment is effective and any side effects are managed appropriately. With proper monitoring and management, Obrenza 100mg Tablet can be an effective treatment option for certain types of cancer.
References
- Lynparza, United States Food and Drug Administration (USFDA), [Revised on May 2020], [Accessed on March 2024], https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208558s014lbl.pdf
- AstraZeneca UK Limited, European Medicines Compendium (emc), [Revised on August 2023], [Accessed on March 2024], https://www.medicines.org.uk/emc/files/pil.9204.pdf
- AstraZeneca Pharmaceuticals LP, [Revised on November 2023], [Accessed on March 2024], https://den8dhaj6zs0e.cloudfront.net/50fd68b9-106b-4550-b5d0-12b045f8b184/00997c3f-5912-486f-a7db-930b4639cd51/00997c3f-5912-486f-a7db-930b4639cd51_viewable_rendition__v.pdf
Safety Advice
Pregnancy: unsafe It is not recommended to take Obrenza 100mg Tablet during pregnancy as it may harm your unborn baby. It is necessary to inform your doctor if you are pregnant or planning to become pregnant.
Lungs: Consult your doctor It is unknown whether Obrenza 100mg Tablet is safe in individuals with liver disorders. Inform your physician if you have any liver problems before starting the treatment.
Breastfeeding: Consult your doctor It is unknown whether Obrenza 100mg Tablet Tablet passes into the breast milk. It is not recommended to nurse a child during and after 1 month of completion of therapy. Please consult your doctor before breastfeeding.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.